Adrenal morphology and cortical function in patients with extrapulmonary tuberculosis: response to antituberculosis treatment

• Published in: Archives of Endocrinology and Metabolism Vol. 68; p. e210514
• Main Authors: Laway, Bashir Ahmad, Blouria, Bhanu Pratap Singh, Jan, Rafi Ahmad, Bhat, Moomin Hussain, Choh, Naseer Ahmad
• Format: Journal Article
• Language: English
• Published: Brazil Sociedade Brasileira de Endocrinologia e Metabologia 29.02.2024; Brazilian Society of Endocrinology and Metabolism
• Subjects: adrenal cortex; Adrenal Glands - diagnostic imaging; Adrenocorticotropic Hormone; Antitubercular Agents - therapeutic use; cortisol; endocrine; extrapulmonary tuberculosis; Humans; Hydrocortisone; Original; Prospective Studies; Tuberculosis; Tuberculosis, Extrapulmonary; cortisol; Tuberculosis; adrenal cortex; extrapulmonary tuberculosis; endocrine
• ISSN: 2359-3997; 2359-4292
• DOI: 10.20945/2359-4292-2021-0514

Enlargement of the adrenal glands and variable adrenocortical function have been reported in patients with pulmonary tuberculosis and, in a few studies, in patients with extrapulmonary tuberculosis (EPTB). However, none of the studies have evaluated the course of the adrenal morphology in these patients. Prospective study including 37 patients with EPTB and 37 healthy age- and sex-matched controls. The adrenal function was evaluated by measurement of cortisol levels at baseline and after stimulation with ACTH (Acton Prolongatum) before and 6 months after antituberculosis treatment. The size of both adrenal glands was evaluated using 64-slice computed tomography (CT) scanning before and 6 months after treatment. The findings were compared with those in a group of healthy matched controls. Clinical and biochemical parameters were comparable between groups. The mean baseline serum cortisol level was significantly lower in the EPTB group (397.1 ± 184.9 nmol/L) compared with the control group (696.3 ± 101.8 nmol/L). Compared with controls, patients with EPTB had significantly lower mean cortisol levels at baseline and 1 hour after ACTH, both before (397 ± 184.9 nmol/L and 750.7 ± 176.8 nmol/L, respectively) and after (529.7 ± 100.4 nmol/L and 1017.2 ± 119.7 nmol/L, respectively) antituberculosis treatment. Both the length and thickness of the right and left adrenal glands were greater in patients with EPTB than in controls but became comparable to those in controls after treatment completion. Patients with EPTB have an enlarged adrenal size and low baseline and stimulated serum cortisol levels. After treatment completion, cortisol levels increased significantly, and the adrenal size normalized in these patients.